Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 26 09:44AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.53 Insider Own11.82% Shs Outstand52.21M Perf Week0.00%
Market Cap52.73M Forward P/E- EPS next Y-0.51 Insider Trans3.86% Shs Float46.04M Perf Month14.36%
Income-23.44M PEG- EPS next Q-0.14 Inst Own35.95% Short Float3.91% Perf Quarter-18.55%
Sales37.07M P/S1.42 EPS this Y12.00% Inst Trans-2.91% Short Ratio4.96 Perf Half Y-60.70%
Book/sh0.42 P/B2.39 EPS next Y22.73% ROA-42.68% Short Interest1.80M Perf Year-69.85%
Cash/sh0.16 P/C6.31 EPS next 5Y- ROE-81.31% 52W Range0.84 - 4.29 Perf YTD-9.01%
Dividend Est.- P/FCF- EPS past 5Y-18.77% ROI-65.83% 52W High-76.46% Beta0.59
Dividend TTM- Quick Ratio1.36 Sales past 5Y15.21% Gross Margin61.60% 52W Low20.24% ATR (14)0.06
Dividend Ex-Date- Current Ratio1.61 EPS Y/Y TTM43.96% Oper. Margin-74.12% RSI (14)46.87 Volatility5.15% 6.13%
Employees198 Debt/Eq0.97 Sales Y/Y TTM2.75% Profit Margin-63.23% Recom1.67 Target Price2.67
Option/ShortYes / Yes LT Debt/Eq0.92 EPS Q/Q25.95% Payout- Rel Volume0.23 Prev Close0.98
Sales Surprise-7.29% EPS Surprise-70.32% Sales Q/Q8.62% EarningsNov 09 AMC Avg Volume362.84K Price1.01
SMA200.20% SMA50-12.39% SMA200-53.36% Trades Volume6,894 Change3.06%
Date Action Analyst Rating Change Price Target Change
Sep-07-23Initiated B. Riley Securities Buy $4
Oct-14-21Resumed B. Riley Securities Buy $10
Sep-17-20Initiated Jefferies Buy $15
Sep-01-20Initiated SVB Leerink Outperform $15
Aug-08-17Reiterated Maxim Group Buy $10 → $12
Oct-26-16Initiated Aegis Capital Buy
May-24-16Initiated Maxim Group Buy $8
Oct-29-15Upgrade WBB Securities Speculative Buy → Buy $13 → $13
May-12-15Reiterated MLV & Co Buy $28 → $21
Apr-01-15Reiterated MLV & Co Buy $28 → $30
Feb-08-24 07:00AM
Jan-17-24 07:15AM
Dec-28-23 07:00AM
Dec-16-23 07:01AM
Dec-13-23 09:15AM
09:42AM Loading…
Nov-10-23 09:42AM
Nov-09-23 05:47PM
Oct-27-23 07:00AM
Oct-05-23 07:00AM
Sep-27-23 07:00AM
Sep-21-23 09:35AM
Sep-19-23 07:00AM
Sep-11-23 11:32AM
04:43PM Loading…
Sep-01-23 04:43PM
Aug-31-23 07:00AM
Aug-14-23 07:00AM
Aug-03-23 09:10AM
Aug-02-23 09:02AM
Aug-01-23 04:23PM
Jul-31-23 07:31AM
Jul-26-23 07:00AM
Jul-19-23 07:00AM
Jul-11-23 07:00AM
Jul-09-23 09:00AM
Jul-07-23 07:07AM
Jun-15-23 07:00AM
Jun-05-23 09:00AM
07:18AM Loading…
May-05-23 07:18AM
May-04-23 10:31AM
May-03-23 07:42AM
May-02-23 04:23PM
Apr-26-23 07:00AM
Apr-20-23 07:00AM
Apr-19-23 07:00AM
Apr-17-23 10:47AM
Mar-29-23 08:30AM
Mar-22-23 08:09AM
Mar-20-23 07:38AM
Mar-17-23 09:10AM
Mar-14-23 07:00AM
Mar-13-23 02:53AM
Mar-10-23 10:33AM
Mar-09-23 04:15PM
Mar-07-23 07:00AM
Feb-27-23 07:00AM
Feb-24-23 07:00AM
Feb-21-23 06:22AM
Feb-15-23 08:20AM
Jan-31-23 07:15AM
Jan-29-23 09:58AM
Jan-23-23 07:00AM
Jan-17-23 07:00AM
Jan-12-23 07:16AM
Dec-29-22 07:00AM
Dec-21-22 07:00AM
Nov-17-22 05:21AM
Nov-14-22 07:00AM
Nov-09-22 05:26AM
Nov-03-22 08:15PM
Nov-02-22 07:10AM
Oct-31-22 07:00AM
Oct-27-22 07:00AM
Oct-25-22 07:32AM
Oct-12-22 07:00AM
Oct-07-22 07:05AM
Oct-06-22 11:12AM
Oct-04-22 01:42PM
Sep-27-22 08:20AM
Sep-14-22 06:39AM
Sep-09-22 07:00AM
Sep-07-22 07:30AM
Aug-23-22 07:02AM
Aug-17-22 07:02AM
Aug-08-22 06:09AM
Aug-05-22 07:40AM
Aug-02-22 06:35PM
Jul-25-22 07:00AM
Jul-08-22 08:44AM
Jul-01-22 07:00AM
Jun-24-22 06:23AM
Jun-02-22 07:00AM
Jun-01-22 07:00AM
May-19-22 07:00AM
May-12-22 11:58AM
May-03-22 04:15PM
May-02-22 07:00AM
Apr-29-22 07:00AM
Apr-28-22 07:00AM
Apr-19-22 07:00AM
Apr-14-22 07:00AM
Apr-12-22 11:21AM
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chan Phillip P.Chief Executive OfficerDec 13Buy1.3375,188100,0001,068,704Dec 15 04:30 PM
BLOCH KATHLEEN P.Chief Financial OfficerDec 13Buy1.3337,59450,000467,941Dec 15 04:32 PM
BATOR MICHAEL G.DirectorDec 13Buy1.3337,59450,000125,394Dec 15 04:33 PM
Deliargyris EfthymiosChief Medical OfficerDec 13Buy1.3322,55730,001348,433Dec 15 04:34 PM
Sobel Alan D.DirectorDec 13Buy1.3322,55730,001101,857Dec 15 04:35 PM
Capponi VincentPresident & COODec 13Buy1.3318,79725,000584,134Dec 15 04:34 PM
Kim JinyDirectorDec 13Buy1.337,51910,00077,819Dec 15 04:31 PM
Jones Edward RaymondDirectorDec 13Buy1.337,51910,00088,834Dec 15 04:32 PM
BATOR MICHAEL G.DirectorAug 07Buy3.172,0006,35087,800Aug 08 08:01 PM
BATOR MICHAEL G.DirectorAug 04Buy3.231,0003,23085,800Aug 08 08:01 PM
BLOCH KATHLEEN P.Interim CFOMay 25Buy2.853,3009,38947,000May 30 07:30 AM
BLOCH KATHLEEN P.Interim CFOMay 10Buy3.1110,00031,05843,700May 12 07:00 AM
Capponi VincentSee RemarksApr 04Option Exercise2.8810,00028,750511,989Apr 05 07:06 PM
Chan Phillip P.Chief Executive OfficerApr 03Option Exercise2.8830,50087,688927,779Apr 05 05:00 PM